Polymorphonuclear leucocyte priming in long intermittent nocturnal haemodialysis patients - Is melatonin a player?

Nephrology Dialysis Transplantation

Volumn 21, Issue 11, 2006, Pages 3196-3201

  Geron, Ronit ^a   Shurtz Swirski, Revital ^a   Sela, Shifra ^a,b   Gurevitch, Yevgeny ^a   Tanasijtchouk, Tatiana ^a   Orr, Zila Shenn ^b   Shkolnik, Galina ^a   Tanhilevski, Olga ^a   Kristal, Batya ^a,b  

^a WESTERN GALILEE HOSPITAL   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Long intermittent nocturnal hemodialysis; Melatonin; Oxidative stress; PMNL priming

Indexed keywords

MELATONIN; SUPEROXIDE;

ACTIMETRY; ADULT; AGED; ARTICLE; CELL SEPARATION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HORMONE BLOOD LEVEL; HUMAN; LONG TERM CARE; MALE; NEUTROPHIL; PRIORITY JOURNAL; QUALITY CONTROL; QUESTIONNAIRE; SCORING SYSTEM; SLEEP; SLEEP DISORDER; WRIST;

CHRONIC DISEASE; CIRCADIAN RHYTHM; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MELATONIN; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; OXIDATIVE STRESS; QUESTIONNAIRES; RENAL DIALYSIS; SLEEP DISORDERS; SUPEROXIDES;

EID: 33750008966     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl359     Document Type: Article

References (22)

1. Walker S, Fine A, Kryger MH. Sleep complaints are common in dialysis unit. Am J Kidney Dis 1995; 26: 751-756
2. Hui DS, Wong TY, Ko FW et al. Prevalence of sleep disturbance in Chinese patients with end stage disease renal failure on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000; 36: 783-788
3. Chokroverty S. Epidemiology and causes of insomnia. Up To Date 2000; 8: 1-6
4. Brzezinski A. Melatonin in humans. N Engl J Med 1997; 336: 186-195
5. Reiter RJ, Tan DX, Manchester LC, Qi W. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species. Cell Biochem Biophys 2001; 34: 237-256
6. Pablos MI, Agapito MT, Gutierrez R et al. Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J Pineal Res 1995; 19: 111-115
7. Dasgupta A, Hussain S, Ahmad S. Increased lipid peroxidation on maintenance hemodialysis. Nephron 1992; 60: 56-59
8. Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER. Oxidative stress in hemodialysis. Q J Med 1994; 16: 339-346
9. Himmelfarb J, Lazarus JM, Hakim R. Reactive oxygen species production by monocytes and polymorphonuclear leucocytes during dialysis. Am J Kidney Dis 1991; 17: 271-276
10. Kristal B, Shurtz-Swirski R, Shasha SM et al. Interaction between erythropoietin and peripheral polymorphonuclear leukocytes in hemodialysis patients. Nephron 1999; 81: 406-413
11. Sela S, Shurtz-Swirski R, Cohen-Mazor M et al. The primed peripheral polymorphonuclear leukocyte - a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol 2005; 16: 2431-2438
12. Ludemann P, Zwernemann S, Lerchl A. Clearance of melatonin and sulfatoxymelatonin by hemodialysis in patients with end stage renal disease. J Pineal Res 2001; 31: 222-227
13. Vaziri ND, Oveisi F, Wierszbiezki M, Shaw V, Sporty LD. Serum Melatonin and 6-Sulfatoxymelatonin in end stage renal disease: Effect of hemodialysis. Artif Org 1993; 17: 764-769
14. Karasek M, Szuflet A, Chrzanowski W, Zylinska K, Swietoslawski J. Circadian serum melatonin profiles in patients suffering from chronic renal failure. Neuroendocrinol Lett 2002; 23 [Suppl 1]: 97-102
15. Zomer J, Peled R, Rubin A, Lavie P. Mini Sleep Questionnaire (MSQ) for screening large populations for EDS complaints. In: Koella WP, Ruther E, Schulz H, eds. Sleep, Stuttgart, New York, Fisher-Verlag: 1984; 467-470
16. Cole RJ, Kripke DF, Gruen W, Mullaney DJ, Gillin JC. Automatic sleep/ wake identification from wrist activity. Sleep 1992; 15: 461-469
17. Sela S, Shurtz-Swirski R, Shapiro G et al. Oxidative stress during hemodialysis: Effect of heparin. Kidney Int 2001; 59: S159-S163
18. Babior BM, Kipnes RS, Curnutte JJ. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 1973; 52: 741-744
19. Zeitzer JM, Daniels JE, Duffy JF et al. Do plasma melatonin decline with age? Am J Med 1999; 107: 432-436
20. Lopez-Gonzalez MA, Calvo JR, Segura JJ, Guerrero JM. Characterization of melatonin binding sites in human peripheral blood neutrophils. Biotechnol Ther 1993; 4: 253-262
21. Silva SO, Ximenes VF, Catalani LH, Campa A. Myeloperoxidase-catalyzed oxidation of melatonin by activated neutrophils. Biochem Biophys Res Commun 2000; 279: 657-662
22. Allegra M, Furtmuller PG, Regelsberger G et al. Mechanism of reaction of melatonin with human myeloperoxidase. Biochem Biophys Res Commun 2001; 282: 380-386